⌘K

Login Start Free

Home/Filings/6-K/0001213900-26-000744

6-K//Foreign company update

NewcelX Ltd. 6-K

Accession 0001213900-26-000744

$NCELCIK 0001783036other

View on SEC.gov Company Profile

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 7:20 AM ET

Size

207.1 KB

Accession

0001213900-26-000744

Documents

3 files

6-K
ea0270504-6k_newcelx.htmPrimary
REPORT OF FOREIGN PRIVATE ISSUER
EX-99.1
ea027050401ex99-1_newcelx.htm
PRESS RELEASE TITLED: "NEWCELX APPOINTS DR. JULIEN BOISDRON, A SWISS BIG PHARMA LEADER IN DIABETES INNOVATION, TO ITS SCIENTIFIC ADVISORY BOARD"
GRAPHIC
ex99-1_001.jpg
GRAPHIC

Issuer

NewcelX Ltd.

CIK 0001783036

Entity typeother

IncorporatedSwitzerland

Related Parties

1

filerCIK 0001783036

Filing Metadata

Form type: 6-K
Filed: Jan 4, 7:00 PM ET
Accepted: Jan 5, 7:20 AM ET
Size: 207.1 KB

View on SEC.gov